Bilateral retinal venous occlusion and unilateral cystoid macular edema in Churg-Strauss syndrome treated with intravitreal triamcinolone

Retina

Volumn 25, Issue 5, 2005, Pages 655-657

  Chen, Simon D M ^a   Lochhead, Jonathan ^a   Satchi, Khami ^a   Patel, C K ^a   Frith, Peggy ^a  

^a OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CHURG STRAUSS SYNDROME; DRUG MECHANISM; HUMAN; MALE; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; STEROID THERAPY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

CHURG-STRAUSS SYNDROME; FUNCTIONAL LATERALITY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 23044491432     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200507000-00018     Document Type: Article

References (5)

1. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-1100.
2. Takanashi T, Uchida S, Arita M, et al. Orbital inflammatory pseudotumor and ischemie vasculitis in Churg-Strauss syndrome: report of two cases and review of the literature. Ophthalmology 2001;108:1129-1133.
3. Penfold PL, Wen L, Madigan MC, et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 2000;121:458-465.
4. Jonas JB, Kreissig I, Degenring RF. Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide. Klin Monatsbl Augenheilkd 2003;220:384-390.
5. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-27.